Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • EQT vs GSK✓SelectedUSD · GSKEQT vs GSK performance historyLatest closeAs of-0.83%11/20
Stock and ETF performance explorer

EQT vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+27.1%
GSK return
+53.4%
Excess return
-26.2%
Maximum drawdown
-28.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-0.8%-0.1%-0.7%-0.8%
7D-7.4%-5.3%-2.1%-7.5%
30D-9.3%-3.7%-5.6%-9.3%
3M-9.0%-7.3%-1.7%-9.0%
6M-14.9%-4.2%-10.7%-14.9%
YTD-7.7%+0.9%-8.6%-7.5%
1Y-12.2%+7.3%-19.5%-11.9%
3Y+27.1%+52.7%-25.6%+15.9%
All+27.1%+53.4%-26.2%+15.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling